CE PANEL VIDEO

As the use of oral oncolytics increases, cancer programs face a number of challenges to ensure high-quality care for their patients. In this video, a panel of leading experts in oncology practice discuss the key issues involved in patient adherence to oral therapeutics, including awareness, education and communication.

PANELISTS

Kimberly M. Hicks, PharmD, MHA (Moderator)

Director of Pharmacy Services at HHCS Health Group of Companies, Orlando, Florida

John Novak, CHA, PA-C

Physician Assistant at Rocky Mountain Cancer Centers, and clinical preceptor at University of Colorado School of Medicine, Aurora, Colorado

Based on the panel discussion, this supplement to JADPRO centers on the role of the advanced practitioner in maintaining adherence in patients on oral oncolytics. Case studies illustrate common challenges to non-adherence, and steps to successful implementation of oral oncolytics are reviewed.

Helping patients adhere to their often-complicated regimens of oral oncolytics begins and ends with communication. Share this resource with your patients as a way to start the conversation about which strategies for adherence will work best for them.

As the number of available oral oncolytics increases rapidly, it becomes more and more important for advanced practitioners to stay current on the medications their patients may be prescribed. This table of over 80 oral agents provides a starting point for keeping up with new approvals.